Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

iChip

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Localizing spontaneously hemostatic colonic diverticular bleeding using VISCOCLEAR gel: A case report.

Annals of medicine and surgery (2012)·2022

Same author

Eosinophilic esophagitis induced by sublingual immunotherapy with cedar pollen: a case report.

Asia Pacific allergy·2021

Same author

Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment.

Proteins·2021

Same author

Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study.

Annals of medicine and surgery (2012)·2020

Same author

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.

Annals of clinical microbiology and antimicrobials·2018

Same author

Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.

Digestive diseases and sciences·2017

Search research articles

Related Experiment Video

Updated: May 11, 2026

A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis

A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis

Published on: September 10, 2014

Trends in diagnostic biochip development.

Eiichiro Ichiishi¹

¹Department of Internal Medicine, International University of Health and Welfare Hospital, 537 Iguchi, Nasushiobara City, Tochigi Pref. 329-2763, Japan. ichiishi@xg7.so-net.ne.jp

Expert Review of Molecular Diagnostics

|May 4, 2013

Summary

Advancements in biochip technology offer potential for early disease diagnosis and prevention, aiding healthcare cost containment. Overcoming technological and societal challenges is crucial for widespread biochip adoption and market expansion.

More Related Videos

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Related Experiment Videos

Last Updated: May 11, 2026

A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis

A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis

Published on: September 10, 2014

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Area of Science:

Biotechnology
Medical Diagnostics
Healthcare Technology

Background:

Aging populations and declining birth rates necessitate innovative healthcare solutions.
Biochips are emerging as key tools for improving healthcare cost-effectiveness.
Current healthcare systems face challenges in early disease detection and prevention.

Purpose of the Study:

To explore the role of biochip technology in healthcare cost containment.
To identify challenges hindering biochip development and market expansion.
To highlight the potential of biochips for early diagnosis, disease prevention, and treatment.

Main Methods:

Review of technological advancements in biochip development.
Analysis of challenges including standardization, ethical, and societal issues.
Examination of economic, institutional, and marketing factors for market expansion.

Main Results:

Biochip technology shows promise for 'super' early diagnosis and disease prevention.
Technological hurdles, alongside social and economic factors, impede biochip market growth.
Addressing multifaceted challenges is essential for realizing biochip potential.

Conclusions:

Biochips can significantly contribute to healthcare cost containment through early detection and prevention.
Successful biochip implementation requires overcoming technological, ethical, and socioeconomic barriers.
The integration of biochip technologies is expected to revolutionize disease management and patient outcomes.